Erin Mulvey

IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas

Xin Huang, Haein Park, J.T. Greene et al. · PLoS ONE · 2015 · 108 citations · Full text

Life Sciences, Immunology, Oncology +17

CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice

Xuguang Chen, Yunyue Wang, David Nelson et al. · PLoS ONE · 2016 · 54 citations · Full text

Medicine, Cancer Biology, Oncology +17

Multicenter Phase 2 Study of Oral azacitidine (CC-486) plus CHOP as initial treatment for peripheral T-cell lymphoma

Jia Ruan, Alison J. Moskowitz, Neha Mehta–Shah et al. · Blood · 2023 · 45 citations · Full text

Medicine, Oncology, Pharmacotherapy +8

Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCL

Peter Martin, Nancy L. Bartlett, Julio C. Chávez et al. · Blood · 2021 · 37 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Phase separation of polyubiquitinated proteins in UBQLN2 condensates controls substrate fate

Isabella M. Valentino, Jeniffer G. Llivicota-Guaman, Thuy P. Dao et al. · Proceedings of the National Academy of Sciences · 2024 · 21 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12